Guinea vs Japan: The number of people with susceptibility test result for rifampicin
Guinea
4,242
in 2021
Japan
4,343
in 2021
Guinea rank
33rd
Japan rank
32nd
The number of people with susceptibility test result for rifampicin over time
- Guinea
- Japan
How they compare
Japan currently reports 4,343 against 4,242 in Guinea, a difference of 101.
Across all 5 years both countries report, Japan has been ahead every year.
Guinea ranks 33rd and Japan ranks 32nd of 155 countries.
Japan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,430 | 7,026 | 5,596 | Japan |
| 2020s | 2,200 | 4,642 | 2,442 | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Guinea or Japan?
- Japan, at 4,343 against 4,242 in Guinea as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Guinea and Japan?
- 101, with Japan ahead.
- How many years of comparable data are there for Guinea and Japan?
- 5 years are reported by both, from 2017 to 2021.
- How do Guinea and Japan rank globally for the number of people with susceptibility test result for rifampicin?
- Guinea ranks 33rd and Japan ranks 32nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.